Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axogen Inc
(NQ:
AXGN
)
12.99
+0.34 (+2.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Axogen Inc
< Previous
1
2
3
4
Next >
CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
August 13, 2024
CytoSorbents CFO Kathleen P. Bloch Retires
From
CytoSorbents
Via
GlobeNewswire
AXGN Stock Earnings: Axogen Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
AXGN stock results show that Axogen beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Parker-Hannifin Posts Upbeat Earnings, Joins Under Armour, Zillow Group, YETI Holdings, Eli Lilly And Other Big Stocks Moving Higher On Thursday
August 08, 2024
Via
Benzinga
Axogen Earnings Preview
March 04, 2024
Via
Benzinga
Axogen, Inc. Announces New Leadership Appointments
August 08, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Reports Second Quarter 2024 Financial Results
August 08, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
July 23, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)
July 01, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
June 24, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia
May 28, 2024
Showcasing Axogen’s Dedication to Fueling Ohio’s Biotechnology Sector Growth
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®
May 16, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference
May 14, 2024
From
Axogen, Inc.
Via
GlobeNewswire
AXGN Stock Earnings: Axogen Beats EPS, Misses Revenue for Q1 2024
May 02, 2024
AXGN stock results show that Axogen beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Axogen, Inc Reports First Quarter 2024 Financial Results
May 02, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
April 29, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
April 16, 2024
From
Axogen, Inc.
Via
GlobeNewswire
AXGN Stock Earnings: Axogen Beats EPS, Beats Revenue for Q4 2023
March 05, 2024
AXGN stock results show that Axogen beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
March 05, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 05, 2024
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.
Via
Benzinga
Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024
February 13, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 5, 2024
March 05, 2024
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
Via
Benzinga
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
February 02, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap
January 18, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Crude Oil Rises Over 2%; Constellation Brands Posts Downbeat Sales
January 05, 2024
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 50 points on Friday. The Dow traded up 0.13% to 37,490.36 while the NASDAQ rose 0.25% to 14,546.77. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 05, 2024
Shares of Applied Therapeutics, Inc.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 05, 2024
Via
Benzinga
Greenbrier Posts Upbeat Earnings, Joins Kura Sushi USA, AxoGen And Other Big Stocks Moving Higher On Friday
January 05, 2024
U.S. stocks traded higher, with the Dow Jones index gaining more than 100 points on Friday. Shares of The Greenbrier Companies, Inc. (NYSE: GBX) rose sharply during Friday’s session following upbeat...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023
January 04, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025
January 04, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Announces Promotions on Research and Development Team
January 04, 2024
Company Also Announces Departure of Angelo Scopelianos, Ph.D.
From
Axogen, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.